QSAR, Ligand Based Design and Pharmacokinetic Studies of Parviflorons Derivatives as Anti-Breast Cancer Drug Compounds Against MCF-7 Cell Line
Crossref DOI link: https://doi.org/10.1007/s42250-020-00207-7
Published Online: 2020-11-29
Published Print: 2021-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abdulrahman, Hadiza Lawal http://orcid.org/0000-0001-5086-2344
Uzairu, Adamu
Uba, Sani
Text and Data Mining valid from 2020-11-29
Version of Record valid from 2020-11-29
Article History
Received: 28 July 2020
Accepted: 12 November 2020
First Online: 29 November 2020
Compliance with Ethical Standards
:
: No conflict of interest.
: Not applicable.